Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
26.03
+0.33 (1.28%)
At close: Dec 5, 2025, 4:00 PM EST
25.97
-0.06 (-0.23%)
After-hours: Dec 5, 2025, 7:59 PM EST
Pfizer Revenue
Pfizer had revenue of $16.65B in the quarter ending September 28, 2025, a decrease of -5.92%. This brings the company's revenue in the last twelve months to $62.79B, up 3.89% year-over-year. In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth.
Revenue (ttm)
$62.79B
Revenue Growth
+3.89%
P/S Ratio
2.35
Revenue / Employee
$775,123
Employees
81,000
Market Cap
148.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
| Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
| Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
| Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
| Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PFE News
- 6 hours ago - HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors - Business Wire
- 1 day ago - Do These 3 Healthcare Stocks Need a Checkup? - The Motley Fool
- 1 day ago - 2 Headwinds Facing Pfizer Stock Going Into 2026 - The Motley Fool
- 1 day ago - Pfizer: The Market Is Still Wrong About It - Seeking Alpha
- 4 days ago - 17 dividend-stock bargains from a value manager with a stellar track record - Market Watch
- 4 days ago - 2 Top Dividend Stocks to Buy Now and Hold For a Decade - The Motley Fool
- 5 days ago - FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks - Investopedia
- 5 days ago - Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men - Market Watch